Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Benproperine→

Benproperine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
2156-27-6
Molecular formula
C21H27NO
Molecular weight
309.4 g/mol
Drug class
Non-opioid antitussivecough suppressant
Mechanism of action
Suppresses the cough reflex through central and peripheral actions; the precise molecular target is not fully established. It is not a mu-opioid receptor agonist.
Indications / reported uses
  • Symptomatic treatment of dry, non-productive cough in countries where benproperine products are authorised; not intended to suppress productive cough where expectoration is required

Sources: NLM MeSH — Benproperine · PubMed — Benproperine antitussive pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Benproperine Environmental Risk Assessment (ERA) (the Benproperine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.